Buy Glenmark Pharmaceuticals Limited and Mahindra & Mahindra Limited

Buy Glenmark Pharmaceuticals Limited:

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Ltd has officially announced a consolidated sales of Rs. 2,801.85 Cr for the third quarter finished on 31-12-2020, which is 4.07% down from its previous quarter sales of Rs. 2,920.60 Cr and 1.20% up from its previous year same quarter sales of Rs. 2,768.52 Cr. The company has reported a net profit after tax of Rs. 248.18 Cr in the previous quarter.

Outlook:

Glenmark Pharmaceuticals Ltd: Experts suggested buy call at current market price: Rs. 576.95 with a target price: Rs. 605; Stoploss: Rs. 575.

Sell Mahindra & Mahindra Limited:

Mahindra & Mahindra Limited

Mahindra & Mahindra Ltd has officially announced a consolidated sales of Rs. 21,867.78 Cr for the third quarter finished on 31-12-2020, which is 8.32% down from its previous quarter sales of Rs. 23,851.74 Cr and 13.58% down from its previous year same quarter sales of Rs. 25,303.23 Cr. The company has reported a net profit after tax of Rs. 272.59 Cr in the previous quarter.

Outlook:

Mahindra & Mahindra Ltd: Experts suggested sell call at current market price: Rs. 752.55 with a target price: Rs. 725; Stoploss: Rs. 765.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

The post Buy Glenmark Pharmaceuticals Limited and Mahindra & Mahindra Limited appeared first on Stock Investor.

Original Article

Published
Categorized as Stock